Hyderabad Telangana, India

Nagendra Babu Bathini

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagendra Babu Bathini. Retrieved from https://idiyas.com/inventor/nagendra-babu-bathini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nagendra Babu Bathini: Innovator in Anti-Cancer Research

Introduction

Nagendra Babu Bathini is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer research through his innovative work. His dedication to scientific advancement is evident in his patented inventions.

Latest Patents

Nagendra Babu Bathini holds a patent for "C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof." This invention describes C5, C6 substituted and/or fused oxindole compounds that are useful as anti-cancer agents. The patent outlines a process for the preparation of these compounds, which are characterized by specific chemical structures and functional groups.

Career Highlights

He is currently associated with the Council of Scientific and Industrial Research, where he continues to engage in groundbreaking research. His work focuses on developing new compounds that can potentially lead to effective cancer treatments.

Collaborations

Some of his notable coworkers include Raji Reddy Chada and Nagarsenkar Atulya, who contribute to the collaborative efforts in research and development within the organization.

Conclusion

Nagendra Babu Bathini's contributions to anti-cancer research through his innovative patents highlight his commitment to advancing medical science. His work not only showcases his expertise but also holds promise for future breakthroughs in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…